Abstract:BACKGROUND:Methyl-CpG-binding protein-2 (MeCP2) is a critical regulator for neural development. Either loss- or gain-of-function leads to severe neurodevelopmental disorders, such as Rett syndrome (RTT) and autism spectrum disorder (ASD). We set out to screen for MECP2 mutations in patients of ASD and determine whether these autism-related mutations may compromise the proper function of MeCP2.METHODS:Whole-exome sequencing was performed to screen MECP2 and other ASD candidate genes for 120 patients diagnosed with ASD. The parents of patients who were identified with MECP2 mutation were selected for further Sanger sequencing. Each patient accomplished the case report form including general information and clinical scales applied to assess their clinical features. Mouse cortical neurons and HEK-293 cells were cultured and transfected with MeCP2 wild-type (WT) or mutant to examine the function of autism-associated MeCP2 mutants. HEK-293 cells were used to examine the expression of MeCP2 mutant constructs with Western blot. Mouse cortical neurons were used to analyze neurites and axon outgrowth by immunofluorescence experiments.RESULTS:We identified three missense mutations of MECP2 from three autism patients by whole-exome sequencing: p.P152L (c.455C>T), p.P376S (c.1162C>T), and p.R294X (c.880C>T). Among these mutations, p.P152L and p.R294X were de novo mutations, whereas p.P376S was inherited maternally. The diagnosis of RTT was excluded in all three autism patients. Abnormalities of dendritic and axonal growth were found after autism-related MeCP2 mutants were expressed in mouse cortical neurons; suggesting that autism-related MECP2 mutations impair the proper development of neurons.CONCLUSIONS:Our study identified genetic mutations of the MECP2 gene in autism patients, which were previously considered to be associated primarily with RTT. This finding suggests that loss-of-function mutations of MECP2 may also lead to autism spectrum disorders.

A multi-model approach defines function altering MECP2 missense variants identified in individuals with autism spectrum disorder

Identification of Autism-Related MECP2 Mutations by Whole-Exome Sequencing and Functional Validation

A novel pathogenic mutation of MeCP2 impairs chromatin association independent of protein levels

Detection of Rare Methyl-CpG Binding Protein 2 Gene Missense Mutations in Patients With Schizophrenia

Modeling antisense oligonucleotide therapy in MECP2 duplication syndrome human iPSC-derived neurons reveals gene expression programs responsive to MeCP2 levels

Detection of Clinically Relevant Genetic Variants in Autism Spectrum Disorder by Whole-Genome Sequencing

A Partial Loss of Function Allele of Methyl-Cpg-binding Protein 2 Predicts a Human Neurodevelopmental Syndrome.

[Mutational analysis of the methyl-CpG-binding protein 2 (MECP2) gene in male autism patients].

MeCP2 links heterochromatin condensates and neurodevelopmental disease

Genome Sequencing Identifies Multiple Deleterious Variants in Autism Patients with More Severe Phenotypes

MeCP2: Multifaceted Roles in Gene Regulation and Neural Development

Dysregulation of miRNA expression and excitation in MEF2C autism patient hiPSC-neurons and cerebral organoids

MECP2 Mutation Spectrum and Its Clinical Characteristics in a Chinese Cohort

Inherited and multiple de novo mutations in autism/developmental delay risk genes suggest a multifactorial model

Gut microbiome and metabolic profiles of mouse model for MeCP2 duplication syndrome

Rett Syndrome Mutation Mecp2 T158a Disrupts Dna Binding, Protein Stability and Erp Responses

Testing the PEST hypothesis using relevant Rett mutations in MeCP2 E1 and E2 isoforms

Aberrant Brain Functional and Structural Developments in MECP2 Duplication Rats

Manipulations of MeCP2 in Glutamatergic Neurons Highlight Their Contributions to Rett and Other Neurological Disorders.

MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons

MeCP2-Related Diseases and Animal Models